NCT02609191

Brief Summary

The main objective of this study is to validate the measurement characteristics of a new bone densitometer, the Stratos DR:

  • Via cross calibration to the results of body composition (BC) measurement results to those of a reference device (the "Discover A" by Hologic) in terms of body fat percentage, lean mass percentage of total body mass and for different subregions (left and right arms, left and right sides, lumbar and thoracic spine, pelvis, left and right legs, head, android area, gynecoid area, visceral region).
  • And by the evaluation of the reproducibility of the BC measurement results in terms of fat mass and lean mass.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 17, 2015

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 20, 2015

Completed
6 months until next milestone

Study Start

First participant enrolled

June 1, 2016

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
Last Updated

November 19, 2025

Status Verified

October 1, 2017

Enrollment Period

1 year

First QC Date

November 17, 2015

Last Update Submit

November 17, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Lin concordance coefficient for fat mass

    The cross calibration between the two devices (Stratos vs Discovery) in terms of fat mass and lean mass is estimated by the appreciation of the Lin concordance coefficient.

    Day 0

  • Lin concordance coefficient for lean mass

    The cross calibration between the two devices (Stratos vs Discovery) in terms of fat mass and lean mass is estimated by the appreciation of the Lin concordance coefficient.

    Day 0

  • RMS-%CV (root-mean-square coefficient of variation) for total fat mass

    Reproducibility will be evaluated in terms of RMS-% CV for calculating the value of the least significant change (LSC). The values of RMS-%CV (root-mean-square coefficient of variation) of the total fat mass and total lean mass will be compared with the limit values recommended by the ISCD. (International Society for Clinical Densitometry)

    Day 0

  • RMS-%CV (root-mean-square coefficient of variation) for total lean mass

    Reproducibility will be evaluated in terms of RMS-% CV for calculating the value of the least significant change (LSC). The values of RMS-%CV (root-mean-square coefficient of variation) of the total fat mass and total lean mass will be compared with the limit values recommended by the ISCD. (International Society for Clinical Densitometry)

    Day 0

Secondary Outcomes (2)

  • Lin's concordance coefficient for Bone Mineral Content

    Day 0

  • Lin's concordance coefficient for Bone Mineral Density

    Day 0

Study Arms (2)

The study population: first 30 patients

EXPERIMENTAL

The study population consists of adult patients referred to the Nuclear Medicine and Medical Biophysics Department of the Nîmes University Hospital for the performance of an osteodensitometric examination. Intervention: Whole body exam using the "Discovery A" Intervention: First whole body exam using the "Stratos DR" Intervention: Second whole body exam using the "Stratos DR"

Device: Whole body exam using the "Discovery A"Device: First whole body exam using the "Stratos DR"Device: Second whole body exam using the "Stratos DR"

The study population: last 20 patients

EXPERIMENTAL

The study population consists of adult patients referred to the Nuclear Medicine and Medical Biophysics Department of the Nîmes University Hospital for the performance of an osteodensitometric examination. Intervention: Whole body exam using the "Discovery A" Intervention: First whole body exam using the "Stratos DR"

Device: Whole body exam using the "Discovery A"Device: First whole body exam using the "Stratos DR"

Interventions

Whole body exam using the "Discovery A" machine made by Hologic.

The study population: first 30 patientsThe study population: last 20 patients

First whole body exam using the "Stratos DR" machine made by the DMS group.

The study population: first 30 patientsThe study population: last 20 patients

Second whole body exam using the "Stratos DR" machine made by the DMS group. This second exam is required for reproducibility purposes.

The study population: first 30 patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The patient must have given his/her informed and signed consent
  • The patient must be insured or beneficiary of a health insurance plan
  • The patient is referred by a doctor for the performance of an osteodensitometry examination.

You may not qualify if:

  • The patient is participating in another study
  • The patient is under judicial protection or any kind of guardianship
  • The patient refuses to sign the consent
  • It is impossible to correctly inform the patient
  • The subject is suffering from a visually significant scoliosis
  • The patient is pregnant or breastfeeding
  • Patient weighing over 160 kg
  • Patient having undergone X-ray examination using a contrast medium such as barium in the 7 days preceding the visit
  • Patient who underwent an examination using γ rays in the 15 days preceding the visit

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHRU de Nîmes - Hôpital Universitaire Carémeau

Nîmes, 30029, France

Location

Related Publications (1)

  • Neron M, Fatton B, Monforte M, Mares P, de Tayrac R, Letouzey V. [Evaluation of urine postvoid residuals in post-partum period: a prospective and descriptive clinical study]. Prog Urol. 2015 Mar;25(4):211-6. doi: 10.1016/j.purol.2014.09.043. Epub 2014 Oct 22. French.

Study Officials

  • Vincent Boudousq, MD

    Centre Hospitalier Universitaire de Nîmes

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 17, 2015

First Posted

November 20, 2015

Study Start

June 1, 2016

Primary Completion

June 1, 2017

Study Completion

June 1, 2017

Last Updated

November 19, 2025

Record last verified: 2017-10

Locations